Loading...
XSHE000004
Market cap281mUSD
Dec 26, Last price  
15.53CNY
1D
6.15%
1Q
4.79%
Jan 2017
-65.41%
Name

Shenzhen Cau Technology Co.

Chart & Performance

D1W1MN
XSHE:000004 chart
P/E
P/S
18.68
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
9.58%
Rev. gr., 5y
-21.40%
Revenues
110m
-33.89%
106,747,75161,376,72445,638,99740,449,54143,314,82460,080,600131,331,49474,503,71897,363,30172,784,56780,608,820120,454,422287,670,026138,605,841366,868,804108,246,697280,531,008288,944,181166,463,289110,048,548
Net income
0k
00619,804002,468,84511,624,0922,989,8912,005,25403,801,3731,247,11839,299,3108,566,7200064,623,126000
CFO
-36m
405,29511,060,815001,428,29846,596,046019,365,73917,562,720009,261,869147,929,75914,439,484003,973,9253,101,5310-36,050,911
Dividend
Jun 19, 20030.024 CNY/sh
Earnings
May 27, 2025

Profile

Shenzhen GuoHua Network Security Technology Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells bio-pharmaceutical products in China. It offers products in the areas of cardiovascular, anti-infective, tumor immunity, nerve/analgesic, API, and gastrointestinal/reproductive. The company also provides clindamycin phosphate, adenosine triphosphate magnesium chloride, diisopropylamine dichloroacetate, cyclophosphamide, cytidine triphosphate disodium, urokinase, and other injection products. In addition, it engages in the development and sale of real estate properties, as well as housing property management activities. The company was formerly known as Shenzhen Cau Technology Co., Ltd and changed its name to Shenzhen GuoHua Network Security Technology Co., Ltd. in November 2020. Shenzhen GuoHua Network Security Technology Co., Ltd., was founded in 1990 and is based in Shenzhen, China.
IPO date
Jan 14, 1991
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
110,049
-33.89%
166,463
-42.39%
288,944
3.00%
Cost of revenue
109,548
194,765
200,769
Unusual Expense (Income)
NOPBT
501
(28,302)
88,175
NOPBT Margin
0.46%
30.52%
Operating Taxes
(16,930)
6,380
Tax Rate
7.24%
NOPAT
17,430
(28,302)
81,795
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
(935)
(33)
BB yield
0.00%
0.00%
Debt
Debt current
3,113
2,420
Long-term debt
14,555
11,416
968
Deferred revenue
472
472
Other long-term liabilities
15,340
4,786
3,044
Net debt
(89,996)
(115,173)
(175,907)
Cash flow
Cash from operating activities
(36,051)
3,102
CAPEX
(336)
Cash from investing activities
407
451
Cash from financing activities
(2,280)
(8,012)
FCF
118,027
87,490
47,881
Balance
Cash
93,706
129,091
169,448
Long term investments
10,845
610
9,847
Excess cash
99,048
121,378
164,848
Stockholders' equity
(1,035,255)
149,348
173,042
Invested Capital
1,251,741
199,388
732,779
ROIC
2.40%
8.22%
ROCE
0.23%
9.80%
EV
Common stock shares outstanding
132,651
146,354
161,283
Price
16.13
66.63%
9.68
-50.15%
19.42
-6.18%
Market cap
2,139,667
51.03%
1,416,706
-54.77%
3,132,124
-8.33%
EV
2,047,965
1,301,551
2,956,774
EBITDA
16,878
(12,969)
99,869
EV/EBITDA
121.34
29.61
Interest
714
315
374
Interest/NOPBT
142.52%
0.42%